approval
saveRYSTIGGO (ROZANOLIXIZUMAB-NOLI) — FDA approval
community read0 votes
Sponsor: UCB INC. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 5
- approval(doxecitine + doxribtimine): KYGEVVI (DOXECITINE) — FDA approvalNov 3, 2025
- approvalzilucoplan: ZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approvalJan 22, 2026
- approvalBRIVARACETAM — FDA approvalJan 30, 2026
- approvalBRIVARACETAM — FDA approvalJan 30, 2026
- approvalfenfluramine hydrochloride: FINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approvalOct 15, 2025
comments(0)
5-min edit window · permanent after that